Pharmacodynamic and pharmacokinetic implications<br /> in the treatment of the elderly with psychiatric drugs <br /> <br />
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2002, Vol 19, Issue 6
Abstract
Physiological changes associated with aging can have a powerful effect on both the pharmacodynamic and the pharmacokinetic properties of prescribed drugs, including psychiatric drugs. Elderly patients are more sensitive to both the therapeutic and the toxic effects of drug regimens. Regarding the pharmacodynamic changes, there is substantial evidence indicating that the function of various neurotransmitter systems is altered by the aging process. Increase in body fat with a simultaneous decrease in total body water, decrement in liver mass and blood flow, as well as reduction of glomerular filtration, tubular function, and renal blood flow result in significant pharmacokinetic modifications. Chronic diseases, which are common in the elderly, further modify pharmacodynamic and pharmacokinetic effects, increasing the incidence and severity of adverse drug effects. Finally, polypharmacy, which is widespread among the elderly, is a very important problem when treating older people. Pharmacokinetic drug interactions can alter the body concentrations of one or more of them. There may also be drug interactions on a pharmacodynamic level. Prescribing drugs to elderly patients, who may be suffering from multiple diseases and taking other drugs, is often unavoidable. Physicians therefore, must employ specific principles to limit the potential dangers in such cases.
Authors and Affiliations
V. BOZIKAS, A. KARAVATOS
Distal renal tubular acidosis (type I) due to an underlying autoimmune disease
No abstract available
Η θεραπεία της σκλήρυνσης κατά πλάκας<br />
Hemoglobin E disease, transient erythroblastopenia
were observed. Two weeks after the fever started, the patient was clinically normal. As hypochromia, microcytosis, numerous target cells and other significant morphologic alterations of red cells were observed, classic...
Screening for cystic fibrosis mutations:<br /> Methods for molecular diagnosis, prenatal diagnosis and carrier identification<br /> amongst high-risk individuals - the Greek experience
OBJECTIVE Cystic fibrosis (CF) is a severe autosomal recessive genetic disease, affecting 1 in 2,500 Caucasians, with 4% being asymptomatic carriers. The aim of this study was to characterize the spectrum of CF mutations...
Bronchoscopic and mycological findings in Aspergillus infections in critically ill patients
Two cases of invasive aspergillosis are presented, one of an aspergilloma and one of Aspergillus tracheobronchitis focusing on the bronchoscopic and mycological findings.